Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis Redazione 4 Febbraio 2021 ...
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials? Redazione 4 Febbraio 2021 ...
Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab Redazione 4 Febbraio 2021 ...
Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Redazione 4 Febbraio 2021 ...
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease Redazione 28 Gennaio 2021 ...
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial Redazione 28 Gennaio 2021 ...
A rationale to prioritise vaccination of HSCT patients against COVID-19 Redazione 28 Gennaio 2021 ...